HP 13C-MRI with 13C-Pyruvate was performed in normal, healthy volunteers over four major body regions and organs, including head/brain, chest/heart, abdomen/liver, and pelvis/kidneys. Many individuals received multiple HP 13C injections and a variety of acquisition sequence. Pyruvate-to-lactate conversion rate measurements were reproducible across days and coil configurations. All injections and imaging were very well tolerated with no adverse effects observed in over 70 scans.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords